Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05878769
Other study ID # GB43374
Secondary ID
Status Recruiting
Phase Phase 3
First received
Last updated
Start date June 28, 2023
Est. completion date June 30, 2027

Study information

Verified date June 2024
Source Hoffmann-La Roche
Contact Reference Study ID Number: GB43374 https://forpatients.roche.com
Phone 888-662-6728
Email global-roche-genentech-trials@gene.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmonary disease (COPD) who have completed the 52-week placebo-controlled treatment period in parent studies GB43311 or GB44332.


Recruitment information / eligibility

Status Recruiting
Enrollment 2000
Est. completion date June 30, 2027
Est. primary completion date June 30, 2027
Accepts healthy volunteers No
Gender All
Age group 40 Years to 90 Years
Eligibility Inclusion Criteria: - Completion of the 52-week treatment period in either parent GB43311 or GB44332 Exclusion Criteria: - Withdrawal of consent and/or premature discontinuation from parent study - Any permanent discontinuation of study drug in parent study - Significant non-compliance in the parent study, specifically defined as missing scheduled visits, per investigator's judgment - Any new diagnosis of asthma according to the Global Initiative for Asthma guidelines or other accepted guidelines since enrolling in the parent study - Any new clinically significant pulmonary disease other than COPD (e.g., pulmonary fibrosis, sarcoidosis, chronic pulmonary embolism or primary pulmonary hypertension, alpha-1-antitrypsin deficiency) since enrolling in the parent study - Any new unstable cardiac disease, myocardial infarction, or New York Heart Association Class III or IV heart failure since enrolling in the parent study

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Astegolimab
Participants will receive SC astegolimab Q2W

Locations

Country Name City State
Argentina Centro Médico Dra de Salvo Buenos Aires
Argentina Fundacion Cidea Buenos Aires
Argentina Instituto de Investigaciones Clinicas-Mar del Plata Buenos Aires
Argentina CARE - Centro de Alergia y Enfermedades Respiratorias Caba
Argentina Centro de Investigaciones Clínicas Belgrano Ciudad Autonoma Buenos Aires
Argentina Instituto de Medicina Respiratoria, IMeR; Clinic/Outpatient Facility Córdoba
Argentina Centro de Especialidades Medicas Lobos Lobos
Argentina Centro de Investigaciones Medicas Mar Del Plata Mar Del Plata
Argentina Instituto Ave Pulmo Mar Del Plata
Argentina Fundacion Scherbovsky Mendoza
Argentina INSARES Mendoza, Mendoza City
Argentina Centro Respiratorio Quilmes Quilmes
Argentina Centro Medico IPAM Rosario
Argentina Instituto Medico Fundacion Grupo Colaborativo Rosario Investigacion y Prevencion Medica Rosario
Argentina Centro Médico Respire San Fernando
Argentina Instituto De Patologias Respiratorias San Miguel de Tucuman
Argentina Centro Integral de Medicina Respiratoria (CIMER) San Miguel de Tucumán
Argentina Instituto De Enfermedades Respiratorias E Investigacion Medica Villa Vatteone
Australia Flinders Medical Centre Bedford Park South Australia
Australia Box Hill Hospital Box Hill Victoria
Australia TrialsWest Pty Ltd Spearwood Western Australia
Belgium Antwerp University Hospital Edegem
Belgium Private Practice Dr Jean Benoit Martinot Erpent
Belgium UZ Leuven Leuven
Belgium AZ Sint-Maarten Mechelen
Belgium AZ Delta Roeselare
Belgium Office of Marc De Meulemeester Thuin
Belgium CHU UCl Namur asbl - Site Godinne Yoir
Bulgaria Medical Centre "Asklepii", OOD Dupnitsa
Bulgaria Specialized Hospital for Active Treatment of Pneumophthisiatric Diseases - Haskovo EOOD Haskovo
Bulgaria Medical Center Leo Clinic EOOD, branch Lovech Lovech
Bulgaria MEDICAL CENTER HERA EOOD; Office of Pulmonology and Phtisiatrics Montana
Bulgaria Specialized Hospital for Active Treatment of Pulmonary Diseases- Pernik EOOD Pernik
Bulgaria Medical center Medconsult Pleven OOD Pleven
Bulgaria Medical center Unimed EOOD Plovdiv
Bulgaria University Multiprofile Hospital for Active Treatment Sveti Georgi EAD Plovdiv
Bulgaria University Multiprofile Hospital for Active Treatment and Emergency Medicine N. I. Pirogov EAD Sofia
Bulgaria Medical Center New rehabilitation center EOOD Stara Zagora
Bulgaria Specialized Hospital for Active Treatment of Pneumophthisiatric Diseases-Vratsa Vratsa
Canada Burlington Lung Clinic Burlington Ontario
Canada Clinique de pneumologie et du sommeil de Lanaudiere Saint-Charles-Borromee Quebec
Canada Dr Anil Dhar Professional Medicine Corporation Windsor Ontario
Chile Enroll SpA - PPDS Providencia
Chile Sociedad Médica SyG SpA Providencia
Chile Centro Internacional de Estudios Clínicos (CIEC) Recoleta
Chile Centro de Estudios Clinicos Santiago
Chile Centro de Investigaciones Medicas Respiratorias CIMER Santiago
Chile Hospital Carlos Van Buren Valparaiso
Czechia MediTrial s.r.o. Jind?ich?v Hradec
Czechia Plicni Ambulance Kralupy nad Vltavou Kralupy nad Vltavou
Czechia KASMED s.r.o. Tabor
Denmark Aalborg Universitetshospital Aalborg
Denmark Gentofte Hospital Hellerup
Denmark Hvidovre Hospital Hvidovre
France Hôpital de La Croix Rousse Lyon
France Hopital Saint Joseph - Marseille Marseille
France Hopital Pasteur II Nice
Germany Zentrum fuer Pneumologie, Onkologie und Schlafmedizin am Diako Augsburg
Germany Gemeinschaftspraxis fuer Herz und Lunge am Bruderw Bamberg
Germany Clinical Studies Pankow Berlin
Germany MECS Research GmbH Berlin
Germany MVZ Jung GbR - Deggingen Deggingen
Germany Medizentrum Essen Borbeck Essen
Germany Praxis Dr med Claus Keller Frankfurt am Main
Germany KPPK Studienzentrum Kroker-Schmidt Koblenz
Germany Asklepios MVZ Bayern GmbH Landsberg
Germany Salvus-Klinische Studien GmbH Leipzig
Germany IKF Pneumologie Mainz Mainz
Germany Praxis für Pneumologie Dr. Silke Mronga & Dr. Lukas Jerrentrup Marburg
Germany Studienzentrum Dr Med Schlenska Peine
Israel Barzilai Medical Center Ashkelon
Israel Shaare Zedek Medical Center Jerusalem
Israel Rabin Medical Center Petach Tiqwa
Israel Sheba Medical Center - PPDS Ramat Gan
Israel Kaplan Medical Center Rehovot
Israel Tel Aviv Sourasky Medical Center PPDS Tel Aviv-Yafo
Korea, Republic of Catholic Univ. of Incheon St.Mary's Hospital Incheon
Korea, Republic of Chonbuk National University Hospital Jeollabuk-do
Korea, Republic of Konkuk University Medical Center Seoul
Korea, Republic of Korea University Anam Hospital Seoul
Mexico CICUM San Miguel Americana Jalisco
Mexico Unidad de Investigacion Clinica En Medicina (Udicem) S.C. Monterrey Nuevo LEON
Mexico Instituto Jalisciense de Investigacion Clinica S.A. de C.V. Santa Cecilia Jalisco
Mexico Unidad Medica de Occidente Santa Elena Alcalde Jalisco
Mexico Centro de Investigacion y Atencion Integral Durango CIAID Victoria de Durango Durango
Netherlands Amphia Ziekenhuis Breda
Netherlands Catharina Hospital; Apotheek Eindhoven
Netherlands Dijklander Ziekenhuis - loc Hoorn Hoorn
New Zealand Aotearoa Clinical Trials Trust Auckland
New Zealand NZ Respiratory & Sleep Institute Auckland
New Zealand Canterbury Respiratory Research Group Christchurch
Poland Centrum Medyczne Bydgoszcz- PRATIA - PPDS Bydgoszcz
Poland Indywidualna Specjalistyczna Praktyka Lekarska lek. Kielce
Poland Centrum Medyczne ALL-MED Krakow
Poland Diamond Clinic Kraków
Poland Niepubliczny Zaklad Opieki Zdrowotnej Centrum Medyczne ProMiMed sp z o.o. sp.k. Kraków
Poland ETG Lodz Lódz
Poland ETG Lublin Lublin
Poland Twoja Przychodnia Centrum Medyczne Nowa Sol Nowa Sól
Poland Ostrowieckie Centrum Medyczne Spolka Cywilna Anna Olec-Cudzik; Krzysztof Cudzik Ostrowiec Swietokrzysk
Poland Centrum Alergologii Teresa Hofman Poznan
Poland EMED Centrum Uslug Medycznych Ewa Smialek Rzeszów
Poland ETG Siedlce Siedlce
Poland PULMAG Grzegorz Gasior Marzena Kociolek Spolka Cywilna Sosnowiec
Poland ETG Neuroscience Sp. z o.o. Warszawa
Poland Dobrostan Gabinety Lekarskie Wroclaw
Romania Neomed Out-Patient Treatment and Diagnosis Medical Center SRL Brasov
Romania Dr. Victor Babes Foundation Bucharest
Romania Leon Daniello Pneumophthisiology Clinical Hospital Cluj-Napoca
Romania Sf. Ioan cel Nou Emergency County Hospital Suceava
South Africa University of Cape Town Lung Institute; Lung Clinical Research Cape Town
South Africa Clinical Trial Systems City Of Tshwane
South Africa Dr A.C Wilhase practice-Reimed Ekurhuleni
South Africa Lakeview Hospital Ekurhuleni
South Africa Langeberg Clinical Trials Kraaifontein
Spain Hospital de San Pedro de Alcantara Caceres
Spain Hospital Clinico San Carlos Madrid
Spain Hospital General Universitario Gregorio Maranon Madrid
Spain Hospital Universitario Fundacion Jimenez Diaz. Madrid
Spain Hospital Universitario Virgen de la Victoria Malaga
Spain Hospital de Merida Merida Badajoz
Spain Hospital Universitario Marques de Valdecilla Santander Cantabria
Spain CHUS H Clinico U de Santiago Santiago de Compostela LA Coruña
Sweden Fysikalisk Medicin i Stockholm AB Lidingö
Sweden PharmaSite Malmö
Sweden ProbarE i Stockholm AB Stockholm
United Kingdom Bradford Royal Infirmary Bradford
United Kingdom Glenfield Hospital Leicester
United States South Texas Medical Research Institute, Inc., dba TTS Research ? ClinEdge ? PPDS Boerne Texas
United States American Health Research Inc. Charlotte North Carolina
United States St Francis Medical Institute ClinEdge PPDS Clearwater Florida
United States Corsicana Medical Research Corsicana Texas
United States SEC Clinical Research LLC - Dothan 2 - ClinEdge - PPDS Dothan Alabama
United States OK Clinical Research Edmond Oklahoma
United States Flushing Road Internal Medicine and Pediatrics - F Flint Michigan
United States Clinical Research of Gastonia Gastonia North Carolina
United States Finlay Medical Research Corporation Greenacres City Florida
United States Hannibal Regional Healthcare System HRMG Hannibal Hannibal Missouri
United States Baylor College of Medicine Houston Texas
United States Jasper Summit Research LLC Jasper Alabama
United States Sierra Clinical Research - ClinEdge - PPDS Las Vegas Nevada
United States Revive Research Institute Lathrup Village Michigan
United States Flourish Research - Leesburg - PPDS Leesburg Florida
United States Pulmonary Specialists of the Palm Beaches Loxahatchee Groves Florida
United States Pulmonary Associates of Mobile PC Mobile Alabama
United States Lowcountry Lung and Critical Care North Charleston South Carolina
United States Florida Institute for Clinical Research, LLC Orlando Florida
United States Temple University Hospital Philadelphia Pennsylvania
United States Cadena Care Institute, LLC Poway California
United States Clinical Research of Rock Hill Rock Hill South Carolina
United States Midwest Chest Consultants Saint Charles Missouri
United States Midwest Clinical Research LLC Saint Louis Missouri
United States Inst. of Healthcare Assessment, Inc. San Diego California
United States Carolina Research Center Shelby North Carolina
United States Sherman Clinical Research - ClinEdge - PPDS Sherman Texas
United States Velocity Clinical Research Spartanburg PPDS Spartanburg South Carolina
United States Exordia Medical Research, Inc. Stow Massachusetts
United States Oakland Medical Research Troy Michigan
United States Allianz Research Institute Inc Westminster California
United States Southeastern Research Center Winston-Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Hoffmann-La Roche

Countries where clinical trial is conducted

United States,  Argentina,  Australia,  Belgium,  Bulgaria,  Canada,  Chile,  Czechia,  Denmark,  France,  Germany,  Israel,  Korea, Republic of,  Mexico,  Netherlands,  New Zealand,  Poland,  Romania,  South Africa,  Spain,  Sweden,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of all adverse events (AEs) Up to 12 weeks after last dose of study treatment
See also
  Status Clinical Trial Phase
Completed NCT05102305 - A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
Completed NCT01867762 - An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Phase 2
Recruiting NCT05562037 - Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA N/A
Terminated NCT04921332 - Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD N/A
Completed NCT03089515 - Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust N/A
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT05552833 - Pulmonary Adaptive Responses to HIIT in COPD N/A
Recruiting NCT05835492 - A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
Recruiting NCT05631132 - May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases? N/A
Completed NCT03244137 - Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
Not yet recruiting NCT03282526 - Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease N/A
Completed NCT02546700 - A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 2
Withdrawn NCT04446637 - Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD Phase 3
Completed NCT04535986 - A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD Phase 3
Recruiting NCT05865184 - Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
Completed NCT03256695 - Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD) Phase 3
Completed NCT03295474 - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
Withdrawn NCT04042168 - Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Phase 4
Completed NCT03414541 - Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease Phase 2
Completed NCT02552160 - DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy